Marion Leboyer
Marion Leboyer is an expert in Psychiatry at Assistance Publique - Hôpitaux de Paris (France). As of October 2026, ScienceLeadR ranks Marion Leboyer in the top 1% of experts worldwide for Bipolar and Related Disorders, Bipolar Disorder and Mood Disorders. Marion Leboyer has authored 1,093 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 9 of them ongoing. SLR score: 3,104 (community average: 125). How the SLR is computed.
LeadR Profile
Psychiatry
Subspecialties: Neurology - Genetics - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 1093
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 19
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 36
Ongoing Clinical Trials
9 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Assessment of microglial activation in patients with schizophrenia stratified for C4 complement by PET using 18F DPA 714 2023-504181-38-00 — complement c4, pathology, schizophrenia, complement system proteins | Phase 2/Phase 3 | Recruiting | 2025 |
| GynMDD Add On to Supportive Psychotherapy in Mild to Moderate Depression NCT07416747 — depression, brain, psychotherapy, dietary supplements, signs and symptoms, probiotics, curcumin, gastrointestinal microbiome, glutamine, mental health, microbiota, psychological well-being | N/A | Recruiting | 2026 |
| Medical Comorbidities in Bipolar Disorder NCT06872398 — comorbidity, bipolar disorder, blood, incidence, blood specimen collection, mental disorders, biomarkers, prevalence, risk factors, therapeutics | N/A | Recruiting | 2024 |
| Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity NCT05946486 — autoantibodies, immunomodulation, mental disorders, central nervous system, rituximab, therapeutics, nervous system, problem behavior, psychotic disorders, child | Phase 3 | Not yet recruiting | 2023 |
| Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia Bipolar Disorder Autism Spectrum Disorder or Resistant Depression NCT05480826 — depression, cells, genes, bipolar disorder, autism spectrum disorder, microscopy, electron, scanning transmission, mental disorders, autistic disorder, child development disorders, pervasive, schizophrenia, problem behavior, dna | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map